DBV Technologies (DBVT) Total Debt (2015 - 2020)
DBV Technologies (DBVT) posted Total Debt of $1.4 million for Q2 2020, up 0.89% sequentially from $1.4 million in Q4 2019, and down 18.09% YoY from $1.8 million in Q3 2019.
DBV Technologies (DBVT) Total Debt (2015 - 2020) Analysis & Trends
DBV Technologies has reported Total Debt for 6 years, with the latest figure at $1.4 million in Q2 2020.
- Quarterly Total Debt fell 18.09% year-over-year to $1.4 million in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $1.4 million (down 18.09% YoY) and the FY2019 annual result came in at $1.4 million, down 49.22% from the prior year.
- Total Debt grew to $1.4 million in Q2 2020 per DBVT's latest filing, from $1.4 million in the prior quarter.
- Over five years, Total Debt peaked at $5.0 million in Q4 2016 and troughed at $1.4 million in Q4 2019.
- A 5-year average of $2.9 million and a median of $2.3 million in 2018 frame the typical range for Total Debt.
- The sharpest annual moves came in 2017 and 2019: Total Debt slipped 2.47% in 2017, then slumped 49.22% in 2019.
- Over 5 years, Total Debt stood at $5.0 million in 2016, then slipped by 2.47% to $4.9 million in 2017, then slumped by 42.09% to $2.8 million in 2018, then plunged by 49.22% to $1.4 million in 2019, then climbed by 0.89% to $1.4 million in 2020.
- According to Business Quant data, Total Debt over the past three periods registered $1.4 million, $1.4 million, and $1.8 million for Q2 2020, Q4 2019, and Q2 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.07 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.34 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 546.77 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.45 Mn |
| Dec 31, 2019 | 1.44 Mn |
| Jun 30, 2019 | 1.77 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Dec 31, 2017 | 4.89 Mn |
| Dec 31, 2016 | 5.01 Mn |
| Dec 31, 2015 | 5.31 Mn |